BYSIBeyondSpring Inc. Ordinary Shares

CSNasdaq (XNAS)·USD

Identity

Security key: 13034
Ticker: BYSI
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2017-03-09
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: BYSI

Detail

Enriched 2026-08-14 20:47

Market cap: $30,510,906.44
Shares outstanding (class): 41,119,820
Shares outstanding (weighted): 41,119,820
SIC: 2834 PHARMACEUTICAL PREPARATIONS
Employees: 44
Location: FLORHAM PARK, NJ
Homepage: https://www.beyondspringpharma.com
Description: BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment. Its first asset, Plinabulin is a novel brain-penetrant microtubule modulator with dendritic cell maturation and vasculature modulation mechanism, which has the potential to help mitigate acquired resistance from prior immune checkpoint inhibitors (ICI) treatment in cancer patients. It is a Selective Immunomodulating Microtubule-Binding Agent (SIMBA), which may provide multiple therapeutic opportunities.

Market cap and share counts drift.

Funds holding this security

6 funds · 6 positions · $1.15M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$564.8K	0.00%	344,384 NS	TICKER
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$432.2K	0.00%	263,550 NS	TICKER
iShares Micro-Cap ETF iShares Trust	IWC	$128.5K	0.01%	78,371 NS	TICKER
1290 VT Micro Cap Portfolio EQ Advisors Trust	—	$9.9K	0.01%	6,039 NS	TICKER
Small Cap Core Fund Northern Funds	—	$8.9K	0.00%	5,429 NS	TICKER
AVIP BlackRock Advantage Small Cap Growth Portf… AuguStar Variable Insurance Products Fund I…	—	$8.9K	0.01%	5,417 NS	TICKER

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

This match is a candidate, not a mapping. N-PORT tickers are filer-entered free text and collide with delisted and foreign symbols. Only 13% of positions carry a ticker at all. Good enough to ask which funds report holding a symbol; not good enough to build exposure reporting on. Prefer the ISIN-resolved link, which is marked FIGI_COMPOSITE.

Funds holding this security

Identifiers

master.security_identifier

TICKERBYSI
CIK0001677940
ISINKYG108301006
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Pharmaceuticals
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: BeyondSpring is a biopharmaceutical company focused on developing cancer therapies, classified under pharmaceuticals.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.